Sort
51,593 grants matching “hepatitis”
EVALUATION OF TREATMENT STRATEGIES TO REDUCE DRUG CRAVING AND HARM IN PEOPLE WITH OPIOID USE DISORDER
$2,039,327Marie Coolahan · University Of Maryland Baltimore · N01 · FY2019 · AI
Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet)
$2,038,447Catherine C McGowan · Vanderbilt University Medical Center · U01 · FY2018 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,034,744Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2020 · AI
Clinical Genomics and Experimental Therapeutics
$2,034,423Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2024 · AA
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytes
$2,033,252Chad Albert Cowan · Massachusetts General Hospital · U01 · FY2015 · HL
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,032,209Stanford University · P01 · FY2001 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,031,035Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2002 · AI
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$2,030,179Stephen A Spector · University Of California, San Diego · UM1 · FY2022 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$2,028,458Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2003 · AI
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,028,320Ofer Levy · Boston Children'S Hospital · U19 · FY2017 · AI
Gene Therapy for Hemophilia
$2,026,513Mortimer Poncz · Children'S Hosp Of Philadelphia · P01 · FY2014 · HL
ADULT AIDS CLINICAL TRIALS UNIT
$2,025,978Ohio State University · U01 · FY2003 · AI
Bridging the gap between type 2 diabetes GWAS and therapeutic targets
$2,025,252Karen L Mohlke · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · DK
Impact of FGF21 on healthspan and lifespan
$2,024,695Vishwa Deep Dixit · Yale University · P01 · FY2017 · AG
Xenobiotic receptors
$2,021,694Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$2,021,622Mark Fredric Cotton · Stellenbosch University · U01 · FY2011 · AI
Correlates of protective immunity to HCV and rational vaccine design
$2,018,828Arash Grakoui · Emory University · U19 · FY2021 · AI
Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment
$2,018,324E. John Wherry · University Of Pennsylvania · U19 · FY2012 · AI
Clinical Genomics and Experimental Therapeutics
$2,017,528Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Molecular Biology and Genetics of Human Tumor Viruses
$2,016,738Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2014 · CA
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence
$2,014,956T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Multi-Center Group to Study Acute Liver Failure in Child
$2,014,896Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2005 · DK
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$2,014,259Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
CIP Microbiome and Genetics Core
$2,012,432Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,012,012Case Western Reserve University · U01 · FY2002 · AI